2019
DOI: 10.15739/ibspr.19.012
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: The fear of Coronary Heart Disease looms over the medical science. In a considerable number of people, hyperlipidemia remains undiagnosed and it lurks silently over years until its consequences appear. Therefore, to manage hyperlipidemia is a medical challenge to reduce the burden of CHD. Statins, HMG CoA reductase inhibitors, have superseded other pharmacological therapies to manage hyperlipidemia. The use of statins is not only costly but also associated with side effects and about one-third of symptomatic p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 30 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?